Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
06/15/1999 | US5911993 For non-insulin dependent diabetes to lower blood sugar; administering extracts from plants of family crassulaceae, genus sinocressula berger; breaking cell walls of crushed leaves, filtration, form powder from concentrated filtrate |
06/15/1999 | US5911992 Suppress appetite, and also acts to induce thermogenesis and inhibit lipogenesis, so as to prevent weight gain, st. john's wort, |
06/15/1999 | US5911987 Cell surface protein and effector cell bonding reagent |
06/15/1999 | US5911886 Device for filtration of cryoprecipitate and its application |
06/15/1999 | US5911704 For delivering a pre-selected molecule into systemic circulation |
06/15/1999 | US5911698 Treatment for cardiovascular and related diseases |
06/15/1999 | CA2151888C Topical composition containing an antioxidant and a bacterial extract; use thereof |
06/15/1999 | CA2099855C Antigastritis agent |
06/15/1999 | CA2000307C Production of hydrogen peroxide |
06/10/1999 | WO1999028748A2 Hla-e binding |
06/10/1999 | WO1999028486A1 Methods of isolating and using cd7+cd34-lin-hematopoietic cells |
06/10/1999 | WO1999028469A1 Compositions and methods for inducing gene expression |
06/10/1999 | WO1999028444A1 Differentiation of adipose stromal cells into osteoblasts and uses thereof |
06/10/1999 | WO1999028443A1 Lineage restricted glial precursors from the central nervous system |
06/10/1999 | WO1999028441A1 Novel bacillus subtilis with antibacterial effects |
06/10/1999 | WO1999028349A2 CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS |
06/10/1999 | WO1999027977A2 Bone matrix, the utilization thereof, therapeutic preparation and kit |
06/10/1999 | WO1999027953A1 Chemoprotective bacterial strains |
06/10/1999 | WO1999027924A2 Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals |
06/10/1999 | WO1999015684A3 Expression of genes in hematopoietic stem cells in hischaemic conditions |
06/10/1999 | WO1999013095A3 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |
06/10/1999 | WO1999013073A3 Viral vector system capable of expressing an apoptosis-associated gene |
06/10/1999 | WO1998004582A8 Isolated peptides derived from mage-2 |
06/10/1999 | DE19808531C1 Heat induction in sheep |
06/10/1999 | CA2312847A1 Differentiation of adipose stromal cells into osteoblasts and uses thereof |
06/10/1999 | CA2311682A1 Lineage restricted glial precursors from the central nervous system |
06/10/1999 | CA2311613A1 Chemoprotective bacterial strains |
06/10/1999 | CA2311574A1 Cells expressing anti-fc receptor binding components |
06/09/1999 | EP0921193A1 Carrier: DNA complexes containing DNA encoding anti-angiogenic peptides and their use in gene therapy |
06/09/1999 | EP0920523A1 Hsv strain lacking functional icp27 and icp34.5 genes |
06/09/1999 | EP0920515A1 A NOVEL HUMAN mRNA EDITING ENZYME |
06/09/1999 | EP0920506A1 Human dbi/acbp-like protein |
06/09/1999 | EP0920323A1 Novel use of phospholipids of animal origin in therapy and/or dietetics |
06/09/1999 | EP0920322A1 Treatment of autoimmune diseases |
06/09/1999 | EP0920305A1 Identification of genes altered in multiple myeloma |
06/09/1999 | CN1218689A Chinese drug preparation for curing hepatopathy and its preparation |
06/09/1999 | CN1218688A Seed pill for curing menoxenia |
06/09/1999 | CN1218682A Bathing medicine for preventing and curing vulva disease |
06/09/1999 | CN1218677A Bone activating and muscle strengthening pill |
06/09/1999 | CN1218673A External use medicine for curing acne |
06/09/1999 | CN1218671A Nutritive liquid for nourishing brain and promoting intelligence growth |
06/09/1999 | CN1218669A Tuberculosis medicine |
06/09/1999 | CN1218666A Nef function inhibitor |
06/09/1999 | CN1218636A Extracting method for nutritive component of spirulina |
06/09/1999 | CN1043554C Technology for producing full placents nutritious agent |
06/08/1999 | US5910306 Transdermal delivery system for antigen |
06/08/1999 | US5910305 Process for enhancing fetus fixation of a pregnant animal to prevent abortion |
06/04/1999 | CA2253011A1 Dna encoding neospora dihydrofolate reductase-thymidylate synthase |
06/03/1999 | WO1999027121A1 Development of viruses resistant to inactivation by the human complement system |
06/03/1999 | WO1999027101A1 Method for preparing adenovirus vectors, vectors so prepared, and uses thereof |
06/03/1999 | WO1999027098A2 A-33 related antigens and their pharmacological uses |
06/03/1999 | WO1999027077A1 Method for producing human intervertebral disc cells |
06/03/1999 | WO1999026678A1 Systems and methods for obtaining a uniform targeted volume of concentrated red blood cells |
06/03/1999 | WO1999026644A1 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
06/03/1999 | WO1999026642A1 Use of the e.coli strain dsm 6601 for treating diarrhoea in veterinary medicine |
06/03/1999 | WO1999026641A1 Use of putamen ovi |
06/03/1999 | WO1999026640A1 Pharmaceutical composition containing extracts of cervus nippon antlers having growth-stimulating activities of hematopoietic stem cells and megakaryocytes |
06/03/1999 | WO1999026639A1 Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood |
06/03/1999 | WO1999026624A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhe and scours |
06/03/1999 | WO1999026623A1 Anti-obesity agent |
06/03/1999 | WO1999026589A2 Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation |
06/03/1999 | WO1999026570A1 Method of cross-linking keratin-based films, sheets, and bulk materials |
06/03/1999 | WO1999026476A1 New psoralens for pathogen inactivation |
06/03/1999 | CA2311763A1 Method for producing human intervertebral disc cells |
06/03/1999 | CA2311642A1 Method for preparing adenovirus vectors, vectors so prepared, and uses thereof |
06/03/1999 | CA2311546A1 Use of putamen ovi |
06/03/1999 | CA2311129A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scours |
06/03/1999 | CA2310852A1 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
06/03/1999 | CA2309358A1 A-33 related antigens and their pharmacological uses |
06/02/1999 | EP0919627A2 Defective Adenoviruses and corresponding transcomplementant celllines |
06/02/1999 | EP0919626A2 Defective Adenoviruses and corresponding transcomplementant celllines |
06/02/1999 | EP0919625A2 Defective Adenoviruses and corresponding transcomplementant celllines |
06/02/1999 | EP0919624A2 Defective Adenoviruses and corresponding transcomplementant celllines |
06/02/1999 | EP0919622A2 Surface expression of enzyme in gene directed prodrug therapy |
06/02/1999 | EP0919239A1 Pharmaceutical composition for the treatment of acute gastroenteritis comprising a rehydration solution.and a compound with synergistic action |
06/02/1999 | EP0919238A2 Crude drug extract containing soluble silicon |
06/02/1999 | EP0919230A1 NMIFA's as anti-inflammatory agents in superficial mammal tissues |
06/02/1999 | EP0918875A1 Novel internal ribosome entry site and vector containing same |
06/02/1999 | EP0918857A1 Human induced tumor protein |
06/02/1999 | EP0918848A1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna |
06/02/1999 | EP0918785A1 Cellular injury response element and uses thereof |
06/02/1999 | EP0918531A2 Use of lactobacillus gg in rehydrating solution |
06/02/1999 | EP0918530A1 Preparation of immunostimulating agents based on propionibacteria |
06/02/1999 | EP0918529A1 Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries |
06/02/1999 | EP0918528A1 Method for treating gastrointestinal damage |
06/02/1999 | EP0918524A1 Mixed chimerism and tolerance |
06/02/1999 | EP0918517A1 Composition of micro-organisms containing omega-3-fatty acid useful as a prophylactic or therapeutic agent against parasitary diseases of animals |
06/02/1999 | EP0918509A1 Biocompatible devices with foam scaffolds |
06/02/1999 | EP0918469A1 Methods and compositions for increasing the anaerobic working capacity in tissues |
06/02/1999 | EP0918464A1 Process for production of colostral milk products and use thereof |
06/02/1999 | EP0757718A4 Methods of use of uncoated gel particles |
06/02/1999 | DE19752900A1 Knochenmatrix und/oder osteogene Zellen, deren Verwendung, therapeutische Zubereitung und Kit Bone matrix, and / or osteogenic cells, their use, preparation and therapeutic kit |
06/02/1999 | CN1218513A Vectors based on recombinant defenctive viral genmoes, and their use in formulation of vaccines |
06/02/1999 | CN1218512A Recombinant adenoviral vectors for human tumour gene therapy |
06/02/1999 | CN1217938A Series of instant powder for common cold |
06/02/1999 | CN1217926A Chinese medicinal composition for nascsinusitis |
06/02/1999 | CN1217924A Medicine for blood generation and preparing method |
06/02/1999 | CN1217916A Oral medicinal liquor prepared from Armilariella tabescens |
06/01/1999 | US5908923 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
06/01/1999 | US5908827 Protein from urine named component B |